INTRODUCTION
Transmyocardial laser revascularization (TMLR) has emerged as an alternative treatment for patients with symptomatic coronary artery disease who are refractory to maximal medical therapy and unsuitable for coronary artery bypass graft or percutaneous transluminal angio-neoangiogenesis elicited by laser injury [8] , has been suggested as a potential mechanism underlying clinical improvement.
Induction of angiogenesis using growth factors is another field of growing interest in the treatment of patients with severe coronary artery disease. The addition of pro-angiogenic factors between the laser channels might induce neovascularization, thus potentiating the effect of TMLR by establishing vascular connections between the neovessels of the channel scars. This hypothesis was tested in the present experimental study, in which a mixture of growth factors derived from bone protein was injected between laser channels in a pig model.
MATERIALS AND METHODS

Laser variables
To create the laser channels, we used a holmium :yttriumaluminium garnet (YAG) laser (CardioGenesis TMLR System, Santa Clara, CA, U.S.A.), which emits a burst of three pulses of energy of wavelength 2.1 µm, which is invisible radiation in the mid-IR portion of the spectrum. The pulsewidth is 350 µs in duration. The output of the holmium :YAG laser is focused into a 365 µm core diameter low-OH quartz fibre with a cylindrical tip (1.75 mm diameter). A 633 nm helium neon laser beam is used as an aiming beam. The pulse repetition rate is 16 Hz for a burst of three pulses, and the energy per pulse is 2.0 J.
Growth factor mixture
Bone protein (Provasc ; Sulzer Carbomedics, Austin, TX, U.S.A.) was obtained by the isolation of protein in the molecular-mass range 10-100 kDa from bovine ( 2 years old) femurs (marrow-free). Based on ELISAs, some angiogenic factors have been identified, such as fibroblast growth factor (FGF) and transforming growth factor-β (TGF-β). It is hypothesized that the mechanism of action is due to the synergy between multiple factors, some of which have not yet been characterized. The growth factor mixture was diluted in 5 % (v\v) Povidone at a concentration of 1 mg of protein\ml.
Animal preparation
The study was performed in 12 pigs (mean body weight 73p4.6 kg). The animals were premedicated with ketaminol (10 mg\kg) and atropine (2 mg) injected intramusculary. A vascular access was established through a vein of the ear. After induction with sodium thiopental (5 mg\kg) through this venous line, the animals were intubated and anaesthesia was maintained by intravenous administration of sodium thiopental as needed. Animals were ventilated with room air. Respiratory rate and stroke volume were adjusted to maintain arterial blood gases within the normal physiological range. Three ECG leads were installed. A left lateral cervictomy was performed to provide vascular access. An arterial line was inserted into the carotid artery. A left lateral thoracotomy was performed through the fifth intercostal space. The pericardium was opened and reflected to form a cradle for suspending the heart.
Experimental protocol
In all the animals, five triads of laser channels were drilled at the mid-height of the left lateral wall. Within each triad, the channels were 1 cm apart. The external opening of each channel was marked with a non-resorbable stitch, in order to identify them later for histology. The animals were allocated randomly to receive an injection either of 100 µg of bovine bone-derived growth factor mixture (0.1 ml of the solution) within the triads (treatment group ; n l 6) or of the same amount of the diluting agent (0.1 ml of 5 % Povidone) (control group ; n l 6). At the end of the operation, the thoracotomy was closed on a chest tube, which was removed after weaning from the ventilator.
Control operation
After 1 month, the animals were anaesthetized using the same protocol. The previous thoracotomy was re-opened and the left lateral myocardial wall was freed. The animals were then killed with an intravenous bolus injection of saturated KCl, and the hearts were rapidly excised for fixation in buffered 4 % formaldehyde for histology.
Histology and morphometry
Channel areas were excised and sliced perpendicular to the channel axis at the mid-level of the myocardial thickness. A tissue block from the middle one-third of the ventricular wall was chosen, dehydrated and embedded in paraffin. Serial sections were stained with haematoxylin and eosin, and with Masson's trichrome stain for microscopic analysis. The vascular endothelium was stained immunohistochemically with an antibody against factor VIII (Dako, Glostrup, Denmark) using the avidin-biotin-complex (ABC)\peroxidase method. The samples were digitized by an image analysis system (Image Pro 3.0 ; Media Cybernetics, Silver Spring, MD, U.S.A.). The areas of interest included the channels themselves and the area between the channels in each triad. The areas analysed were delineated with a cursor, and units were converted from pixels into mm# by a calibration procedure by use of a reference system. The boundary of the channel with the surrounding myocardium was irregular, and all the areas containing fibrous tissue were included in the channel area. The structures stained for factor VIII were retained for analysis. The vascular density of the areas analysed was expressed as the number of these structures per mm#. The vascular structures with at least one layer of smooth muscle cells were considered as arteriolar structures, and were also counted separately. The difference between total vascular and arteriolar density counts was considered as representing the capillary density. Moreover, the diameter of each artery was measured. Because of the variable angle of section through the vessels, their shorter diameters were taken into consideration.
Photographs of the areas of interest were taken at a low magnification power of i20, in order to cover the largest area possible and to avoid the bias of regional differences. For computed analysis these images were digitized and underwent a total magnification of i140 for counting of the vascular structures.
Statistics
The results of the morphological analysis are given as meanspS.D. The vascular densities of the different areas were compared using Student's t test. Values were considered to differ significantly if P 0.05.
RESULTS
The laser channels were completely replaced by scar tissue, leaving no central patent lumen. On the trichromestained sections the scar was composed of numerous and thickened collagen fibres, as well as substantial amounts of small vessels.
The capillary density of myocardial areas within the triads was significantly greater in the group receiving the bovine bone-derived growth factor mixture than in the control group (14.3p3.5\mm# and 5.7p1.4\mm# respectively ; P 0.001) (Figure 1) . The difference was also significant when considering arteriolar density (0.7p0.4\mm# and 0.2p0.1\mm# respectively ; P 0.001). For comparison, the capillary and arteriolar densities of the TMLR channel scars were 48.7p9.7\mm# and 1.9p0.5\mm# respectively in the angiogenic group, and 46.3p13.7\mm# and 2.3p1.3\mm# respectively in the control group (Figure 1) (no significant differences) .
The mean diameters of the arterioles within the channels (for both groups) and in the areas between the triads for the treatment and control groups were 72.7p37 µm, 73.3p45 µm and 70.5p30 µm respectively. No significant differences were found between any combination of groups.
Notably, there was no evidence of calcification in the group receiving the bovine bone-derived growth factor mixture, which is related the use of Povidone as the dilution medium instead of the matrix required for bone formation.
DISCUSSION
With the mounting evidence that TMLR channels do not remain patent, neovascularization has been suggested as a possible explanation for the observed therapeutic benefit of TMLR. The addition of pro-angiogenic factors between the channels might stimulate neovascularization, thus potentiating the effect of TMLR by establishing vascular connections between the neovessels of the channel scars. In support of this hypothesis, Pelletier et al. [9] reported a study in which rats underwent left coronary artery ligation with or without transmyocardial channels created with a needle in the ischaemic area. The group with transmyocardial channels had significantly greater vascular density, with a peak at 1 week postoperatively, and showed increased levels of both TGF-β and basic FGF (bFGF). Thus, in this rat model, transmyocardial revascularization is associated with a significant angiogenic response, which appears to be mediated by the release of certain angiogenic growth factors.
Bone protein has been shown to be capable of inducing ectopic bone through the process of endochondral bone formation. An experimental model of bone induction has been established, in which ectopic ossicles can be elicted reproducibly within 3 weeks by implanting collagen pellets containing bone protein into the back muscle of mice [10, 11] . These ossicles have been found to be highly vascularized. In the same model, an anti-angiogenic agent has been demonstrated to inhibit ectopic bone formation at the initial step [12] . Moreover, individual growth factors have been shown to play an essential role in bone formation. When applied directly to a freshly created fracture in the rabbit fibula, a single injection of bFGF and hyaluronan results in the stimulation of callus formation, increased bone formation, and earlier restoration of mechanical strength at the fracture site [13] . Inactivation of vascular endothelial growth factor (VEGF) results in the complete disruption of the normal vascular pattern of the growth plate in juvenile mice, and VEGF-mediated blood vessel invasion is indeed essential for coupling the resorption of cartilage to bone formation [14] . In the present study, in order to produce an angiogenic effect only, without any bone induction, bone protein was injected in Povidone instead of supplying the matrix that is required for bone formation.
Fleischer et al. [15] injected VEGF, or adenovirus vector with or without the gene encoding for profilin, within triads of CO # laser channels in a pig model. When the animals were killed after 28 days, it was observed that the inflammatory response secondary to injection of adenovirus vector was greater than that seen with VEGF. An increase in vascularity was noted in all treatment groups ; however, molecular interventions with VEGF and profilin adenovirus did not augment the neovascular response. Therefore, in that model, molecular interventions appear to stimulate more inflammation but no additional angiogenesis. Two other strategies may improve these results : the use of gene therapy to allow prolonged release of growth factor, and the use of a combination of growth factors for their synergism.
Recently, considerable interest has been shown in gene therapy as a means to deliver growth factors. The idea is to produce the protein locally and for a given period of time. The ways of administration are multiple : intravascular injection, seeded stent, coated angioplasty balloon or pericardial instillation. Sayeed-Shah et al. [16] combined TMLR and injection of plasmid DNA encoding VEGF into chronically ischaemic pig myocardium. These workers demonstrated that wall motion abnormalities were completely reversed within 6 weeks, in contrast with hearts that had received either TMLR or plasmid DNA encoding for VEGF. However, despite the enthusiasm for gene therapy, it has not yet been demonstrated that its theoretical advantages are associated with superiority of therapeutic efficacy compared with the use of native or recombinant protein.
Our present study demonstrates that, in this pig model, the addition of the growth factor mixture to TMLR significantly stimulates neoangiogenesis in the areas adjacent to the channels, but not within the channel scars. The latter are themselves strongly vascularized. The size of the arterioles was similar in both areas, suggesting a similar neovascularization pattern. The animals undergoing injection of the diluting agent instead of the bovine bone-derived growth factor mixture were used as a control group because the vascular density of the areas adjacent to the channels in these animals was similar to that reported for normal myocardium [17] .
Our results are at variance with the study of Fleischer et al. [15] . One possible explanation for the difference is that bone protein is a mixture of many factors which may act synergistically. Two in vitro studies [18, 19] have demonstrated that the combined administration of VEGF and bFGF to endothelial cell cultures in threedimensional collagen gels results in much greater and more rapid capillary tubule formation than the additive effects of either mitogen alone. Similar results were reported in vivo with the combinations of VEGF and FGF [20] and of scatter factor\hepatocyte growth factor and VEGF [21] in a rabbit model of hindlimb ischaemia. Therefore there is growing evidence that the combination of growth factors potentiates their effects, and in this respect the bone protein growth factor mixture has the potential to be a useful product.
